# GABRG1

## Overview
The GABRG1 gene encodes the gamma-aminobutyric acid type A (GABA(A)) receptor subunit gamma1, which is a critical component of the GABA(A) receptor, a ligand-gated ion channel involved in inhibitory neurotransmission in the central nervous system. This receptor plays a pivotal role in mediating fast synaptic inhibition by facilitating the influx of chloride ions into neurons, thereby reducing neuronal excitability and contributing to the regulation of physiological processes such as anxiety, sleep, and muscle relaxation (Ittiwut2008Interpopulation). The GABA(A) receptor, which includes the gamma1 subunit, is a pentameric complex that is essential for maintaining the balance between neuronal excitation and inhibition, crucial for normal brain function (Ittiwut2008Interpopulation). The expression of GABRG1 is subject to complex regulatory mechanisms involving trans-acting elements, which influence its expression in the brain (Mulligan2012Complex). Additionally, GABRG1 has clinical significance in the context of brain tumors, such as gliomas and medulloblastomas, where its expression levels can impact prognosis and treatment strategies (Badalotti2024Gene; Kallay2019Modulating).

## Function
The GABRG1 gene encodes the gamma1 subunit of the GABA(A) receptor, a crucial component of the central nervous system's inhibitory neurotransmission system. This receptor is a ligand-gated ion channel that facilitates the entry of chloride ions into neurons, resulting in hyperpolarization and decreased neuronal excitability. This process is essential for regulating various physiological functions, including anxiety, sleep, and muscle relaxation (Ittiwut2008Interpopulation).

In healthy human cells, the GABA(A) receptor, including the gamma1 subunit encoded by GABRG1, plays a significant role in fast synaptic inhibition. This receptor is composed of five subunits that form a chloride channel, which is activated by the neurotransmitter gamma-aminobutyric acid (GABA). The proper functioning of this receptor is vital for maintaining the balance between neuronal excitation and inhibition, which is crucial for normal brain function and preventing disorders related to excessive neuronal activity (Ittiwut2008Interpopulation).

The expression of GABRG1 is regulated by trans-acting elements, indicating that its expression is influenced by genetic variants located on different chromosomes or far from the gene itself. This regulation is complex and involves multiple genetic factors that modulate its expression in the brain (Mulligan2012Complex).

## Clinical Significance
The GABRG1 gene, which encodes the gamma1 subunit of the GABA-A receptor, plays a significant role in the prognosis of glioma, a type of brain tumor. Studies have shown that higher expression levels of GABRG1 are associated with longer overall survival in patients with lower-grade gliomas, suggesting its potential as a prognostic marker (Badalotti2024Gene). This indicates that alterations in the expression of GABRG1 can influence tumor progression and patient outcomes.

In the context of medulloblastoma, another type of brain tumor, GABRG1 is highly expressed in the SHH subgroup of patients. This expression pattern may have implications for the diagnosis and treatment of specific medulloblastoma subtypes (Kallay2019Modulating).

While the role of GABRG1 in epilepsy is not explicitly detailed, the gene is part of a cluster with other GABA receptor subunit genes, which have been implicated in epilepsy syndromes. Variants in these genes can lead to altered receptor function and contribute to the pathogenesis of epilepsy, although specific mutations in GABRG1 have not been highlighted in the context provided (Butler2018De).


## References


[1. (Badalotti2024Gene) Rafael Badalotti, Matheus Dalmolin, Osvaldo Malafaia, Jurandir M. Ribas Filho, Rafael Roesler, Marcelo A. C. Fernandes, and Gustavo R. Isolan. Gene expression of gabaa receptor subunits and association with patient survival in glioma. Brain Sciences, 14(3):275, March 2024. URL: http://dx.doi.org/10.3390/brainsci14030275, doi:10.3390/brainsci14030275. This article has 2 citations and is from a peer-reviewed journal.](https://doi.org/10.3390/brainsci14030275)

[2. (Butler2018De) Kameryn M Butler, Olivia A Moody, Elisabeth Schuler, Jason Coryell, John J Alexander, Andrew Jenkins, and Andrew Escayg. De novo variants in gabra2 and gabra5 alter receptor function and contribute to early-onset epilepsy. Brain, 141(8):2392–2405, June 2018. URL: http://dx.doi.org/10.1093/brain/awy171, doi:10.1093/brain/awy171. This article has 70 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1093/brain/awy171)

[3. (Ittiwut2008Interpopulation) Chupong Ittiwut, Jennifer Listman, Apiwat Mutirangura, Robert Malison, Jonathan Covault, Henry R. Kranzler, Atapol Sughondhabirom, Nuntika Thavichachart, and Joel Gelernter. Interpopulation linkage disequilibrium patterns of gabra2 and gabrg1 genes at the gaba cluster locus on human chromosome 4. Genomics, 91(1):61–69, January 2008. URL: http://dx.doi.org/10.1016/j.ygeno.2007.08.007, doi:10.1016/j.ygeno.2007.08.007. This article has 14 citations and is from a peer-reviewed journal.](https://doi.org/10.1016/j.ygeno.2007.08.007)

[4. (Mulligan2012Complex) Megan K. Mulligan, Xusheng Wang, Adrienne L. Adler, Khyobeni Mozhui, Lu Lu, and Robert W. Williams. Complex control of gaba(a) receptor subunit mrna expression: variation, covariation, and genetic regulation. PLoS ONE, 7(4):e34586, April 2012. URL: http://dx.doi.org/10.1371/journal.pone.0034586, doi:10.1371/journal.pone.0034586. This article has 54 citations and is from a peer-reviewed journal.](https://doi.org/10.1371/journal.pone.0034586)

[5. (Kallay2019Modulating) Laura Kallay, Havva Keskin, Alexandra Ross, Manali Rupji, Olivia A. Moody, Xin Wang, Guanguan Li, Taukir Ahmed, Farjana Rashid, Michael Rajesh Stephen, Kirsten A. Cottrill, T. Austin Nuckols, Maxwell Xu, Deborah E. Martinson, Frank Tranghese, Yanxin Pei, James M. Cook, Jeanne Kowalski, Michael D. Taylor, Andrew Jenkins, Daniel A. Pomeranz Krummel, and Soma Sengupta. Modulating native gabaa receptors in medulloblastoma with positive allosteric benzodiazepine-derivatives induces cell death. Journal of Neuro-Oncology, 142(3):411–422, February 2019. URL: http://dx.doi.org/10.1007/s11060-019-03115-0, doi:10.1007/s11060-019-03115-0. This article has 21 citations and is from a peer-reviewed journal.](https://doi.org/10.1007/s11060-019-03115-0)